Skip to content

Clinical trials

Phase 3 Hyperinsulinism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperinsulinism Phase: Phase 3 Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20131
20191
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Rezolute2
Assistance Publique - Hôpitaux de Paris1
Bethesda Diabetes Research Center1
M.D. Anderson Cancer Center1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperinsulinism6
Hypoglycemia2
Neoplasms2
Obesity2
Adenoma, Islet Cell1
Congenital Hyperinsulinism1
Craniopharyngioma1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Diabetes, Gestational1

Trials

Showing 76 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.